Loss of SYK has been associated with breast cancer progression14 and with poor prognosis and metastasis in a range of epithelial tumours15, 16, implicating it as a potential driver of cross-metastatic seeding and treatment resistance in this patient. This evidence concerns the gene SYK and breast cancer.